Doximity, Inc. $DOCS Shares Sold by SBI Securities Co. Ltd.

SBI Securities Co. Ltd. lowered its position in shares of Doximity, Inc. (NASDAQ:DOCS) by 70.0% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 24,816 shares of the company’s stock after selling 57,791 shares during the quarter. SBI Securities Co. Ltd.’s holdings in Doximity were worth $1,522,000 at the end of the most recent quarter.

A number of other large investors also recently bought and sold shares of DOCS. Allworth Financial LP lifted its stake in Doximity by 1,448.7% in the second quarter. Allworth Financial LP now owns 8,719 shares of the company’s stock valued at $535,000 after buying an additional 8,156 shares during the last quarter. Fountainhead AM LLC boosted its stake in Doximity by 12.8% during the 2nd quarter. Fountainhead AM LLC now owns 11,545 shares of the company’s stock valued at $708,000 after purchasing an additional 1,310 shares during the period. ProShare Advisors LLC boosted its stake in Doximity by 4.1% during the 2nd quarter. ProShare Advisors LLC now owns 5,920 shares of the company’s stock valued at $363,000 after purchasing an additional 232 shares during the period. Campbell & CO Investment Adviser LLC acquired a new position in shares of Doximity during the second quarter valued at $888,000. Finally, Prospera Financial Services Inc acquired a new position in Doximity during the 2nd quarter valued at about $237,000. Institutional investors own 87.19% of the company’s stock.

Insider Buying and Selling

In other news, Director Timothy S. Cabral sold 20,000 shares of Doximity stock in a transaction that occurred on Wednesday, September 24th. The shares were sold at an average price of $75.00, for a total value of $1,500,000.00. Following the transaction, the director owned 3,221 shares of the company’s stock, valued at $241,575. This trade represents a 86.13% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Kira Scherer Wampler sold 2,000 shares of Doximity stock in a transaction on Monday, November 3rd. The stock was sold at an average price of $66.44, for a total transaction of $132,880.00. Following the completion of the transaction, the director owned 19,839 shares in the company, valued at $1,318,103.16. This trade represents a 9.16% decrease in their position. The SEC filing for this sale provides additional information. Over the last quarter, insiders have sold 32,000 shares of company stock worth $2,339,580. Insiders own 31.30% of the company’s stock.

Doximity Stock Performance

NASDAQ DOCS opened at $50.89 on Thursday. The firm’s 50 day moving average price is $68.35 and its two-hundred day moving average price is $62.60. Doximity, Inc. has a twelve month low of $47.66 and a twelve month high of $85.21. The stock has a market cap of $9.53 billion, a price-to-earnings ratio of 50.89, a PEG ratio of 4.10 and a beta of 1.36.

Doximity (NASDAQ:DOCS) last released its earnings results on Thursday, November 6th. The company reported $0.45 earnings per share for the quarter, beating the consensus estimate of $0.38 by $0.07. Doximity had a return on equity of 21.75% and a net margin of 36.60%.The company’s revenue for the quarter was up 23.2% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.30 EPS. Doximity has set its FY 2026 guidance at EPS. Q3 2026 guidance at EPS. On average, research analysts forecast that Doximity, Inc. will post 0.99 EPS for the current fiscal year.

Analyst Ratings Changes

A number of research analysts recently commented on DOCS shares. Canaccord Genuity Group lowered their price objective on shares of Doximity from $67.00 to $58.00 and set a “hold” rating on the stock in a research note on Monday. Bank of America raised Doximity from a “neutral” rating to a “buy” rating and increased their price target for the company from $75.00 to $82.00 in a research note on Monday, October 27th. Evercore ISI dropped their price objective on Doximity from $81.00 to $70.00 and set an “outperform” rating on the stock in a research note on Friday, November 7th. Raymond James Financial set a $75.00 target price on Doximity in a research note on Wednesday, September 10th. Finally, Piper Sandler lifted their target price on Doximity from $65.00 to $69.00 and gave the stock an “overweight” rating in a report on Monday, August 11th. One research analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating, seven have assigned a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $69.59.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.